TMEM9B and type 2 diabetes mellitus: The disrupted ribosomal biogenesis orchestrated by TMEM9B-AS1 holds physiological implications, potentially contributing toward the decrease in skeletal muscle mass often observed in individuals with type 2 diabetes.